COVID-19: Sanofi, GSK say vaccine shows positive results
French pharmaceuticals giant Sanofi SA and the UK’s GlaxoSmithKline PLC yesterday reported “strong immune responses” in early tests of their COVID-19 vaccine, raising hopes it could join the fight against the pandemic. The companies said the results of the phase 2 study would enable them to move to a late-stage trial in the coming weeks — a reversal of fortune after their research was dealt a setback late last year. The experimental vaccine “achieved strong rates of neutralizing antibody responses, in line with those measured in people who have recovered from COVID-19, in all adult a...